Company / Current Liabilities
Wave Life Sciences Ltd. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$95.1M
FY2025
5-year range
$64.2M / $186.4M
FY2021-FY2025
Trend
-14.3%
vs FY2024
Sector context
#100 of 213
Health Care
What the data says
At $95M, Wave Life Sciences Ltd.'s current liabilities ranks #114 of 213 in the Health Care sector. Current Liabilities has fluctuated over the past 10 years, ranging from $12M in FY2016 to $186M in FY2023.
Based on SEC 10-K filings.
$95M in FY2025 with a 5-year CAGR of -4.7%.
Improved from $186M to $95M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +10.0%
- 5-Year CAGR
- -4.7%
- 10-Year CAGR
- -
Sector benchmark
#114 of 213 in Health CareTop 53% of 213This company $95.1M Sector average $1.6B
▼
-94.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -4.7%, indicating a declining trend.
- In FY2025, current liabilities decreased 14.3% year-over-year.
- Ranks #100 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $95.1M | -14.3% |
| FY2024 | $111.0M | -40.5% |
| FY2023 | $186.4M | +160.7% |
| FY2022 | $71.5M | +11.4% |
| FY2021 | $64.2M | -47.0% |
| FY2020 | $121.0M | +2.4% |
| FY2019 | $118.2M | -9.1% |
| FY2018 | $130.0M | +614.9% |
| FY2017 | $18.2M | +49.7% |
| FY2016 | $12.2M | +218.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026